Gleason Score for Prostate Cancer

The Gleason score grades prostate cancer aggressiveness by adding the two predominant histologic patterns on biopsy.

Primary grade
Small, uniform glands. Well-differentiated.+1More stroma between glands, well to moderately differentiated.+2Distinctly infiltrative margins. Moderately differentiated.+3Irregular masses of neoplastic glands. Poorly differentiated.+4Only occasional gland formation. Poorly differentiated.+5
Secondary grade
Small, uniform glands. Well-differentiated.+1More stroma between glands, well to moderately differentiated.+2Distinctly infiltrative margins. Moderately differentiated.+3Irregular masses of neoplastic glands. Poorly differentiated.+4Only occasional gland formation. Poorly differentiated.+5
Tertiary grade
Small, uniform glands. Well-differentiated.+1More stroma between glands, well to moderately differentiated.+2Distinctly infiltrative margins. Moderately differentiated.+3Irregular masses of neoplastic glands. Poorly differentiated.+4Only occasional gland formation. Poorly differentiated.+5

Indications for Use

Start by grading biopsy cores using primary + secondary Gleason patterns to classify tumor differentiation and aggressiveness 1 [Level III evidence]. Clinical utility includes risk stratification (low, intermediate, high) informing treatment intensity, prognosis (higher scores predict metastasis and mortality), and guiding management such as active surveillance vs. radical therapy 2 [Level II evidence].

Insights & Cautions

Predicts tumor aggressiveness and risk of recurrence or metastasis; higher patterns (especially pattern 4/5) drive prognosis per NCCN validation cohorts (>26,000 men) showing sharp declines in 5‑yr recurrence‑free survival across Grade Groups 1→5 1 [Level I evidence]. Caution: biopsy undergrading, especially hidden pattern 4/5; tertiary pattern 5 confers risk similar to Gleason 8–10 2 [Level II evidence]. Interobserver variability persists.